+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Digital Biomarkers Market - Global Forecast 2026-2032- Product Image
Digital Biomarkers Market - Global Forecast 2026-2032- Product Image
New

Digital Biomarkers Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 199 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5924667
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The digital biomarkers market is rapidly transforming healthcare delivery, integrating cutting-edge technology with clinical practice to support precision medicine. Senior decision-makers must understand these shifts to drive value across product development, regulatory alignment, and operational strategy.

Market Snapshot: Digital Biomarkers Market Growth and Outlook

The Digital Biomarkers Market expanded from USD 2.36 billion in 2025 to USD 2.61 billion in 2026 and is projected to sustain a CAGR of 11.16%, reaching USD 4.95 billion by 2032. This market expansion is shaped by broad adoption of wearable sensors, mobile health applications, and advanced analytics. Vendors are leveraging technology to support early disease detection and efficient patient management, while providers prioritize integrating these insights into clinical workflows. The evolving environment reflects heightened collaboration between healthcare and technology sectors, with value creation anchored in scalable solutions and outcomes-focused care delivery.

Scope & Segmentation

  • Component Architecture: Hardware includes implantable sensors, external monitoring devices, and comprehensive wearable suites. Software platforms process physiological signals to generate digital endpoints that inform real-time clinical or research decisions.
  • Biomarker Types: Solutions address both active markers, which capture user-initiated inputs, and passive markers, offering seamless, background health monitoring. Segment strategies differ in terms of user involvement and integration into existing clinical systems.
  • Functionalities: Product offerings encompass tools for continuous physiological monitoring, event-based alerts for timely interventions, and periodic assessment platforms that help ensure adherence and compliance.
  • Applications: Key areas span diagnostics, optimizing drug development protocols, and ongoing patient monitoring. Digital biomarkers support early condition identification, patient risk assessment, clinical trial endpoints, and care management optimization.
  • End Users: Academic research institutes, biotechnology developers, hospitals, clinics, and pharmaceutical firms are accelerating adoption, using digital biomarkers to streamline studies and drive clinical practice improvements.
  • Therapeutic Areas: Cardiology, endocrinology, neurology, oncology, and pulmonology represent highly active fields; each leverages new sensor types and advanced analytics to address complex disease management and enhance patient outcomes.
  • Regions Analysed: Americas, EMEA, and Asia-Pacific markets, each characterized by distinct regulatory environments, infrastructure maturity, and technology uptake rates.
  • Technology Drivers: Advancements include sensor miniaturization, artificial intelligence, wireless network integration, improved data analytics, and evolving regulatory standards that facilitate broader digital biomarker adoption.

Key Takeaways for Decision-Makers

  • Advanced analytics and machine learning are central to extracting actionable insights from continuous health data, supporting informed clinical guidance.
  • Regulatory frameworks are evolving to accommodate digital health solutions, with increased acceptance of real-world evidence for validation and pathway acceleration.
  • Cross-sector partnerships enable seamless data exchange and evidence generation, aligning technology providers with clinical and regulatory stakeholders.
  • Local manufacturing and the incorporation of open-source hardware contribute to supply chain resilience and help mitigate procurement uncertainties.
  • Deployment of outcome-based reimbursement models reinforces the value proposition of digital biomarkers in value-driven care frameworks.
  • Competitive advantage rests on robust clinical evidence, transparent data governance, and platforms designed around intuitive user experiences for both clinicians and patients.

Tariff Impact: 2025 Shifts in Component Procurement

Significant U.S. tariffs on select electronic components and sensor modules in 2025 have increased manufacturing costs for digital biomarker devices. In response, manufacturers are pursuing long-term supplier agreements, upscaling local production capacity, and considering assembly in tariff-exempt geographies. A notable trend is the adoption of open-source hardware and participation in consortium-led procurement, which help sustain access to advanced sensors and manage overall expense. These strategies underscore supply chain flexibility and the sector’s ability to maintain momentum amid shifting trade conditions.

Methodology & Data Sources

Research findings are grounded in structured expert interviews, review of peer-reviewed scientific publications, regulatory documentation, and rigorously validated quantitative datasets. Data triangulation ensures all insights are credible and representative, while real-world case studies contextualize analysis for operational decision-making.

The Digital Biomarkers Market: Why This Report Matters

  • Equips executives to prioritize product and process innovation, enhance regulatory preparedness, and achieve supply chain optimization.
  • Provides actionable analysis to address technological, reimbursement, and compliance challenges across diverse regional markets.
  • Supports effective capital allocation through evidence-based assessments of growth levers, roadblocks, and segment prioritization.

Conclusion

The digital biomarkers market is evolving as a collaborative ecosystem, influenced by rapid technological refinement and fresh regulatory approaches. Decision-makers who embrace evidence-based strategies are well positioned to capitalize on emerging opportunities and advance clinical and operational outcomes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Digital Biomarkers Market, by Component
8.1. Hardware
8.1.1. Implantables
8.1.2. Sensors
8.1.3. Wearables
8.1.3.1. Fitness Bands
8.1.3.2. Smartwatches
8.2. Software
9. Digital Biomarkers Market, by Biomarker Type
9.1. Active
9.2. Passive
10. Digital Biomarkers Market, by Functionality
10.1. Continuous
10.2. Event-Driven
10.3. Periodic
11. Digital Biomarkers Market, by Therapeutic Area
11.1. Cardiology
11.1.1. Arrhythmia
11.1.2. Heart Failure
11.2. Endocrinology
11.2.1. Diabetes Mellitus
11.2.2. Thyroid Disorders
11.3. Neurology
11.3.1. Alzheimer's Disease
11.3.2. Parkinson's Disease
11.4. Oncology
11.4.1. Breast Cancer
11.4.2. Prostate Cancer
11.5. Pulmonology
12. Digital Biomarkers Market, by Application
12.1. Disease Diagnostics
12.2. Drug Development
12.3. Patient Monitoring
13. Digital Biomarkers Market, by End User
13.1. Academic & Research Institutes
13.2. Biotechnology Firms
13.3. Hospitals & Clinics
13.4. Pharmaceutical Companies
14. Digital Biomarkers Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Digital Biomarkers Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Digital Biomarkers Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Digital Biomarkers Market
18. China Digital Biomarkers Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. ActiGraph, LLC
19.6. Adherium Limited
19.7. Altoida, Inc.
19.8. Amgen Inc.
19.9. Aural Analytics, Inc. by Linus Health, Inc.
19.10. Biofourmis Pte. Ltd.
19.11. Biogen Inc.
19.12. Brainomix Limited
19.13. Chugai Pharmaceutical Co., Ltd.
19.14. Eli Lilly and Company
19.15. Empatica Inc.
19.16. F. Hoffmann-La Roche Ltd.
19.17. Feel Therapeutics Inc.
19.18. GERO PTE. LTD.
19.19. Huma Therapeutics Limited
19.20. ICON PLC
19.21. IXICO PLC
19.22. Koneksa Health Inc.
19.23. Medable Inc.
19.24. Owkin, Inc.
19.25. Sonde Health, Inc
19.26. Teva Pharmaceutical Industries Ltd.
19.27. Verily Life Sciences, LLC
19.28. VivoSense, Inc
List of Figures
FIGURE 1. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL DIGITAL BIOMARKERS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL DIGITAL BIOMARKERS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY FUNCTIONALITY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA DIGITAL BIOMARKERS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY IMPLANTABLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY IMPLANTABLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY IMPLANTABLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY SENSORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY SENSORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY SENSORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY WEARABLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY WEARABLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY WEARABLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY WEARABLES, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY FITNESS BANDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY FITNESS BANDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY FITNESS BANDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY SMARTWATCHES, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY SMARTWATCHES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY SMARTWATCHES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY ACTIVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY ACTIVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY ACTIVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY PASSIVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY PASSIVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY PASSIVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY CONTINUOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY CONTINUOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY CONTINUOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY EVENT-DRIVEN, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY EVENT-DRIVEN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY EVENT-DRIVEN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY PERIODIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY PERIODIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY PERIODIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY ARRHYTHMIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY ARRHYTHMIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY ARRHYTHMIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY HEART FAILURE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY HEART FAILURE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY ENDOCRINOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY ENDOCRINOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY ENDOCRINOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY ENDOCRINOLOGY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY DIABETES MELLITUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY DIABETES MELLITUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY DIABETES MELLITUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY THYROID DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY THYROID DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY THYROID DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY ALZHEIMER'S DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY ALZHEIMER'S DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY ALZHEIMER'S DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY PARKINSON'S DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY PARKINSON'S DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY BREAST CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY BREAST CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY PROSTATE CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY PROSTATE CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY PULMONOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY PULMONOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY PULMONOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY DISEASE DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY DISEASE DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY DISEASE DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY DRUG DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY DRUG DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY PATIENT MONITORING, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY PATIENT MONITORING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY PATIENT MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 112. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 113. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
TABLE 114. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY WEARABLES, 2018-2032 (USD MILLION)
TABLE 115. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 116. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
TABLE 117. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 118. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 119. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY ENDOCRINOLOGY, 2018-2032 (USD MILLION)
TABLE 120. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 121. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 122. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 123. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 124. NORTH AMERICA DIGITAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. NORTH AMERICA DIGITAL BIOMARKERS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 126. NORTH AMERICA DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
TABLE 127. NORTH AMERICA DIGITAL BIOMARKERS MARKET SIZE, BY WEARABLES, 2018-2032 (USD MILLION)
TABLE 128. NORTH AMERICA DIGITAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 129. NORTH AMERICA DIGITAL BIOMARKERS MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
TABLE 130. NORTH AMERICA DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 131. NORTH AMERICA DIGITAL BIOMARKERS MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 132. NORTH AMERICA DIGITAL BIOMARKERS MARKET SIZE, BY ENDOCRINOLOGY, 2018-2032 (USD MILLION)
TABLE 133. NORTH AMERICA DIGITAL BIOMARKERS MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 134. NORTH AMERICA DIGITAL BIOMARKERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 135. NORTH AMERICA DIGITAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 136. NORTH AMERICA DIGITAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 137. LATIN AMERICA DIGITAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 138. LATIN AMERICA DIGITAL BIOMARKERS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 139. LATIN AMERICA DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
TABLE 140. LATIN AMERICA DIGITAL BIOMARKERS MARKET SIZE, BY WEARABLES, 2018-2032 (USD MILLION)
TABLE 141. LATIN AMERICA DIGITAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 142. LATIN AMERICA DIGITAL BIOMARKERS MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
TABLE 143. LATIN AMERICA DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 144. LATIN AMERICA DIGITAL BIOMARKERS MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 145. LATIN AMERICA DIGITAL BIOMARKERS MARKET SIZE, BY ENDOCRINOLOGY, 2018-2032 (USD MILLION)
TABLE 146. LATIN AMERICA DIGITAL BIOMARKERS MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 147. LATIN AMERICA DIGITAL BIOMARKERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 148. LATIN AMERICA DIGITAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 149. LATIN AMERICA DIGITAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY WEARABLES, 2018-2032 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY ENDOCRINOLOGY, 2018-2032 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 163. EUROPE DIGITAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 164. EUROPE DIGITAL BIOMARKERS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 165. EUROPE DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
TABLE 166. EUROPE DIGITAL BIOMARKERS MARKET SIZE, BY WEARABLES, 2018-2032 (USD MILLION)
TABLE 167. EUROPE DIGITAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 168. EUROPE DIGITAL BIOMARKERS MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
TABLE 169. EUROPE DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 170. EUROPE DIGITAL BIOMARKERS MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 171. EUROPE DIGITAL BIOMARKERS MARKET SIZE, BY ENDOCRINOLOGY, 2018-2032 (USD MILLION)
TABLE 172. EUROPE DIGITAL BIOMARKERS MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 173. EUROPE DIGITAL BIOMARKERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 174. EUROPE DIGITAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 175. EUROPE DIGITAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 176. MIDDLE EAST DIGITAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 177. MIDDLE EAST DIGITAL BIOMARKERS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 178. MIDDLE EAST DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
TABLE 179. MIDDLE EAST DIGITAL BIOMARKERS MARKET SIZE, BY WEARABLES, 2018-2032 (USD MILLION)
TABLE 180. MIDDLE EAST DIGITAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 181. MIDDLE EAST DIGITAL BIOMARKERS MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
TABLE 182. MIDDLE EAST DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 183. MIDDLE EAST DIGITAL BIOMARKERS MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 184. MIDDLE EAST DIGITAL BIOMARKERS MARKET SIZE, BY ENDOCRINOLOGY, 2018-2032 (USD MILLION)
TABLE 185. MIDDLE EAST DIGITAL BIOMARKERS MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 186. MIDDLE EAST DIGITAL BIOMARKERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 187. MIDDLE EAST DIGITAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 188. MIDDLE EAST DIGITAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 189. AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 191. AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
TABLE 192. AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY WEARABLES, 2018-2032 (USD MILLION)
TABLE 193. AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 194. AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
TABLE 195. AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 196. AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 197. AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY ENDOCRINOLOGY, 2018-2032 (USD MILLION)
TABLE 198. AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 199. AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 200. AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 201. AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 202. ASIA-PACIFIC DIGITAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 203. ASIA-PACIFIC DIGITAL BIOMARKERS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 204. ASIA-PACIFIC DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
TABLE 205. ASIA-PACIFIC DIGITAL BIOMARKERS MARKET SIZE, BY WEARABLES, 2018-2032 (USD MILLION)
TABLE 206. ASIA-PACIFIC DIGITAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 207. ASIA-PACIFIC DIGITAL BIOMARKERS MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
TABLE 208. ASIA-PACIFIC DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 209. ASIA-PACIFIC DIGITAL BIOMARKERS MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 210. ASIA-PACIFIC DIGITAL BIOMARKERS MARKET SIZE, BY ENDOCRINOLOGY, 2018-2032 (USD MILLION)
TABLE 211. ASIA-PACIFIC DIGITAL BIOMARKERS MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 212. ASIA-PACIFIC DIGITAL BIOMARKERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 213. ASIA-PACIFIC DIGITAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 214. ASIA-PACIFIC DIGITAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 215. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 216. ASEAN DIGITAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 217. ASEAN DIGITAL BIOMARKERS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 218. ASEAN DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
TABLE 219. ASEAN DIGITAL BIOMARKERS MARKET SIZE, BY WEARABLES, 2018-2032 (USD MILLION)
TABLE 220. ASEAN DIGITAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 221. ASEAN DIGITAL BIOMARKERS MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
TABLE 222. ASEAN DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 223. ASEAN DIGITAL BIOMARKERS MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 224. ASEAN DIGITAL BIOMARKERS MARKET SIZE, BY ENDOCRINOLOGY, 2018-2032 (USD MILLION)
TABLE 225. ASEAN DIGITAL BIOMARKERS MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 226. ASEAN DIGITAL BIOMARKERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 227. ASEAN DIGITAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 228. ASEAN DIGITAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 229. GCC DIGITAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 230. GCC DIGITAL BIOMARKERS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 231. GCC DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
TABLE 232. GCC DIGITAL BIOMARKERS MARKET SIZE, BY WEARABLES, 2018-2032 (USD MILLION)
TABLE 233. GCC DIGITAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 234. GCC DIGITAL BIOMARKERS MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
TABLE 235. GCC DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 236. GCC DIGITAL BIOMARKERS MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 237. GCC DIGITAL BIOMARKERS MARKET SIZE, BY ENDOCRINOLOGY, 2018-2032 (USD MILLION)
TABLE 238. GCC DIGITAL BIOMARKERS MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 239. GCC DIGITAL BIOMARKERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 240. GCC DIGITAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 241. GCC DIGITAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 242. EUROPEAN UNION DIGITAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 243. EUROPEAN UNION DIGITAL BIOMARKERS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 244. EUROPEAN UNION DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
TABLE 245. EUROPEAN UNION DIGITAL BIOMARKERS MARKET SIZE, BY WEARABLES, 2018-2032 (USD MILLION)
TABLE 246. EUROPEAN UNION DIGITAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 247. EUROPEAN UNION DIGITAL BIOMARKERS MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
TABLE 248. EUROPEAN UNION DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 249. EUROPEAN UNION DIGITAL BIOMARKERS MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 250. EUROPEAN UNION DIGITAL BIOMARKERS MARKET SIZE, BY ENDOCRINOLOGY, 2018-2032 (USD MILLION)
TABLE 251. EUROPEAN UNION DIGITAL BIOMARKERS MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 252. EUROPEAN UNION DIGITAL BIOMARKERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 253. EUROPEAN UNION DIGITAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 254. EUROPEAN UNION DIGITAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 255. BRICS DIGITAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 256. BRICS DIGITAL BIOMARKERS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 257. BRICS DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
TABLE 258. BRICS DIGITAL BIOMARKERS MARKET SIZE, BY WEARABLES, 2018-2032 (USD MILLION)
TABLE 259. BRICS DIGITAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 260. BRICS DIGITAL BIOMARKERS MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
TABLE 261. BRICS DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 262. BRICS DIGITAL BIOMARKERS MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 263. BRICS DIGITAL BIOMARKERS MARKET SIZE, BY ENDOCRINOLOGY, 2018-2032 (USD MILLION)
TABLE 264. BRICS DIGITAL BIOMARKERS MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 265. BRICS DIGITAL BIOMARKERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 266. BRICS DIGITAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 267. BRICS DIGITAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 268. G7 DIGITAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 269. G7 DIGITAL BIOMARKERS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 270. G7 DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
TABLE 271. G7 DIGITAL BIOMARKERS MARKET SIZE, BY WEARABLES, 2018-2032 (USD MILLION)
TABLE 272. G7 DIGITAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 273. G7 DIGITAL BIOMARKERS MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
TABLE 274. G7 DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 275. G7 DIGITAL BIOMARKERS MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 276. G7 DIGITAL BIOMARKERS MARKET SIZE, BY ENDOCRINOLOGY, 2018-2032 (USD MILLION)
TABLE 277. G7 DIGITAL BIOMARKERS MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 278. G7 DIGITAL BIOMARKERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 279. G7 DIGITAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 280. G7 DIGITAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 281. NATO DIGITAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 282. NATO DIGITAL BIOMARKERS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 283. NATO DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
TABLE 284. NATO DIGITAL BIOMARKERS MARKET SIZE, BY WEARABLES, 2018-2032 (USD MILLION)
TABLE 285. NATO DIGITAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 286. NATO DIGITAL BIOMARKERS MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
TABLE 287. NATO DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 288. NATO DIGITAL BIOMARKERS MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 289. NATO DIGITAL BIOMARKERS MARKET SIZE, BY ENDOCRINOLOGY, 2018-2032 (USD MILLION)
TABLE 290. NATO DIGITAL BIOMARKERS MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 291. NATO DIGITAL BIOMARKERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 292. NATO DIGITAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 293. NATO DIGITAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 294. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 295. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 296. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 297. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
TABLE 298. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, BY WEARABLES, 2018-2032 (USD MILLION)
TABLE 299. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 300. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
TABLE 301. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 302. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 303. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, BY ENDOCRINOLOGY, 2018-2032 (USD MILLION)
TABLE 304. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 305. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 306. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 307. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 308. CHINA DIGITAL BIOMARKERS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 309. CHINA DIGITAL BIOMARKERS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 310. CHINA DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
TABLE 311. CHINA DIGITAL BIOMARKERS MARKET SIZE, BY WEARABLES, 2018-2032 (USD MILLION)
TABLE 312. CHINA DIGITAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 313. CHINA DIGITAL BIOMARKERS MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
TABLE 314. CHINA DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 315. CHINA DIGITAL BIOMARKERS MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 316. CHINA DIGITAL BIOMARKERS MARKET SIZE, BY ENDOCRINOLOGY, 2018-2032 (USD MILLION)
TABLE 317. CHINA DIGITAL BIOMARKERS MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 318. CHINA DIGITAL BIOMARKERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 319. CHINA DIGITAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 320. CHINA DIGITAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Digital Biomarkers market report include:
  • ActiGraph, LLC
  • Ada Health GmbH
  • Adherium Limited
  • Advanced Data Systems Corporation
  • Altoida, Inc.
  • American Well Corporation
  • Amgen Inc.
  • Aptar Digital Health
  • athenahealth, Inc.
  • Aural Analytics, Inc. by Linus Health, Inc.
  • Babylon Healthcare Services Ltd
  • Biofourmis Pte. Ltd.
  • Biogen Inc.
  • Brainomix Limited
  • Cantata Health, LLC
  • Chugai Pharmaceutical Co., Ltd.
  • Cisco Systems, Inc.
  • Click Therapeutics, Inc.
  • Cognizant Technology Solutions Corporation
  • ConcertAI LLC
  • DnaNexus, Inc.
  • eClinicalWorks, LLC
  • Eli Lilly and Company
  • Empatica Inc.
  • Epic Systems Corporation
  • F. Hoffmann-La Roche Ltd.
  • Feel Therapeutics Inc.
  • GE HealthCare Technologies Inc.
  • GERO PTE. LTD.
  • Harris Computer Corporation
  • Huma Therapeutics Limited
  • ICON PLC
  • iHealth Labs Inc.
  • International Business Machines Corporation
  • InterSystems Corporation
  • IXICO PLC
  • Johnson & Johnson Services, Inc.
  • Kasha Global Inc.
  • Koneksa Health Inc.
  • Koninklijke Philips N.V.
  • Lupin Limited
  • Medable Inc.
  • Medtronic PLC
  • Owkin, Inc.
  • Sonde Health, Inc
  • Teva Pharmaceutical Industries Ltd.
  • Verily Life Sciences, LLC
  • VivoSense, Inc

Table Information

Report AttributeDetails
No. of Pages199
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 2.61 Billion
Forecasted Market Value ( USD ) by 2032 $ 4.95 Billion
Compound Annual Growth Rate11.1%
Regions CoveredGlobal
No. of Companies Mentioned49

Related Topics

Related Reports

Digital Biomarkers - Market Insights, Competitive Landscape, and Market Forecast - 2032 - Product Image

Digital Biomarkers - Market Insights, Competitive Landscape, and Market Forecast - 2032

  • Report
  • 150 Pages
  • Global
From
Digital Biomarkers Market 2025-2029 - Product Image

Digital Biomarkers Market 2025-2029

  • Report
  • 220 Pages
  • Global
From
Digital Biomarkers Market Report 2025 - Product Image

Digital Biomarkers Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Digital Biomarkers: Global Markets - Product Image

Digital Biomarkers: Global Markets

  • Report
  • 129 Pages
  • Global
From
Psychiatric Digital Biomarkers Market Size, Share & Trends Analysis Report by Type (Wearables, Mobile-Based Applications, Sensors), Clinical Practice (Diagnostic, Monitoring, Predictive & Prognostic), End-Use, and Region with Growth Forecasts, 2025-2030 - Product Image

Psychiatric Digital Biomarkers Market Size, Share & Trends Analysis Report by Type (Wearables, Mobile-Based Applications, Sensors), Clinical Practice (Diagnostic, Monitoring, Predictive & Prognostic), End-Use, and Region with Growth Forecasts, 2025-2030

  • Report
  • 100 Pages
  • Global
From

About the Market

The Digital Biomarker market is a subset of the Internet and E-Commerce industry, focusing on the development and use of digital biomarkers. Digital biomarkers are digital tools that measure and track health-related data, such as physical activity, sleep, and nutrition. This data can be used to monitor and improve health outcomes, as well as to develop personalized treatments. Digital biomarkers are increasingly being used in clinical trials, as well as in the development of digital therapeutics. The Digital Biomarker market is growing rapidly, driven by the increasing demand for personalized healthcare solutions. This market is expected to continue to grow as more healthcare providers and pharmaceutical companies adopt digital biomarkers. Some companies in the Digital Biomarker market include Apple, Fitbit, Google, Microsoft, and Philips. These companies are developing digital biomarkers for a variety of applications, including health monitoring, disease management, and clinical trials. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.